Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

Clinical trial NCT01193842 · COMPLETED

Trial details

NCT number: NCT01193842
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

AIDS-Related Plasmablastic Lymphoma AIDS-Related Primary Effusion Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Stage I Grade 3 Follicular Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma HIV Infection

Start date: 2010-10-06
Primary completion: 2016-11-12
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.